These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


409 related items for PubMed ID: 32024703

  • 1. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
    Fischer C, Bozza F, Merino Merino XJ, Pedroso C, de Oliveira Filho EF, Moreira-Soto A, Schwalb A, de Lamballerie X, Netto EM, Bozza PT, Sarno M, Brites C, Gotuzzo E, Talledo M, Drexler JF.
    mSphere; 2020 Feb 05; 5(1):. PubMed ID: 32024703
    [Abstract] [Full Text] [Related]

  • 2. Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus.
    Fumagalli MJ, de Souza WM, Romeiro MF, de Souza Costa MC, Slhessarenko RD, Figueiredo LTM.
    J Clin Microbiol; 2019 May 05; 57(5):. PubMed ID: 30787146
    [Abstract] [Full Text] [Related]

  • 3. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
    Fumagalli MJ, de Souza WM, de Castro-Jorge LA, de Carvalho RVH, Castro ÍA, de Almeida LGN, Consonni SR, Zamboni DS, Figueiredo LTM.
    J Virol; 2021 Nov 09; 95(23):e0112221. PubMed ID: 34549980
    [Abstract] [Full Text] [Related]

  • 4. Serological Responses in Patients Infected with Mayaro Virus and Evaluation of Cross-Protective Responses against Chikungunya Virus.
    Bopp NE, Jencks KJ, Siles C, Guevara C, Vilcarromero S, Fernández D, Halsey ES, Ampuero JS, Aguilar PV.
    Am J Trop Med Hyg; 2021 Nov 29; 106(2):607-609. PubMed ID: 34844213
    [Abstract] [Full Text] [Related]

  • 5. Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.
    Fumagalli MJ, de Souza WM, Espósito DLA, Silva A, Romeiro MF, Martinez EZ, da Fonseca BAL, Figueiredo LTM.
    Virol J; 2018 Jul 24; 15(1):112. PubMed ID: 30041676
    [Abstract] [Full Text] [Related]

  • 6. Limited Evidence for Infection of Urban and Peri-urban Nonhuman Primates with Zika and Chikungunya Viruses in Brazil.
    Moreira-Soto A, Carneiro IO, Fischer C, Feldmann M, Kümmerer BM, Silva NS, Santos UG, Souza BFCD, Liborio FA, Valença-Montenegro MM, Laroque PO, da Fontoura FR, Oliveira AVD, Drosten C, de Lamballerie X, Franke CR, Drexler JF.
    mSphere; 2018 Jul 24; 3(1):. PubMed ID: 29404420
    [Abstract] [Full Text] [Related]

  • 7. Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential.
    Webb EM, Azar SR, Haller SL, Langsjoen RM, Cuthbert CE, Ramjag AT, Luo H, Plante K, Wang T, Simmons G, Carrington CVF, Weaver SC, Rossi SL, Auguste AJ.
    Sci Rep; 2019 Dec 31; 9(1):20399. PubMed ID: 31892710
    [Abstract] [Full Text] [Related]

  • 8. Co-circulation of two Alphaviruses in Burkina Faso: Chikungunya and O'nyong nyong viruses.
    Tinto B, Bicaba B, Kagoné TS, Kayiwa J, Rabe I, Merle CSC, Zango A, Ayouba A, Salinas S, Kania D, Simonin Y.
    PLoS Negl Trop Dis; 2024 Jun 31; 18(6):e0011712. PubMed ID: 38870214
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.
    Prince HE, Altrich ML, Nowicki MJ.
    Clin Vaccine Immunol; 2016 Oct 31; 23(10):825-830. PubMed ID: 27535838
    [Abstract] [Full Text] [Related]

  • 10. Combining anti-IgM and IgG immunoassays for comprehensive chikungunya virus diagnostic testing.
    Mendoza EJ, Robinson A, Dimitrova K, Mueller N, Holloway K, Makowski K, Wood H.
    Zoonoses Public Health; 2019 Dec 31; 66(8):909-917. PubMed ID: 31449360
    [Abstract] [Full Text] [Related]

  • 11. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
    Campos RK, Preciado-Llanes L, Azar SR, Kim YC, Brandon O, López-Camacho C, Reyes-Sandoval A, Rossi SL.
    Front Immunol; 2020 Dec 31; 11():591885. PubMed ID: 33224148
    [Abstract] [Full Text] [Related]

  • 12. Cryptic circulation of chikungunya virus in São Jose do Rio Preto, Brazil, 2015-2019.
    Zini N, Ávila MHT, Cezarotti NM, Parra MCP, Banho CA, Sacchetto L, Negri AF, Araújo E, Bittar C, Milhin BHGA, Miranda Hernandes V, Dutra KR, Trigo LA, Cecílio da Rocha L, Alves da Silva R, Celestino Dutra da Silva G, Fernanda Pereira Dos Santos T, de Carvalho Marques B, Lopes Dos Santos A, Augusto MT, Mistrão NFB, Ribeiro MR, Pinheiro TM, Maria Izabel Lopes Dos Santos T, Avilla CMS, Bernardi V, Freitas C, Gandolfi FA, Ferraz Júnior HC, Perim GC, Gomes MC, Garcia PHC, Rocha RS, Galvão TM, Fávaro EA, Scamardi SN, Rogovski KS, Peixoto RL, Benfatti L, Cruz LT, Chama PPF, Oliveira MT, Watanabe ASA, Terzian ACB, de Freitas Versiani A, Dibo MR, Chiaravalotti-Neto F, Weaver SC, Estofolete CF, Vasilakis N, Nogueira ML.
    PLoS Negl Trop Dis; 2024 Mar 31; 18(3):e0012013. PubMed ID: 38484018
    [Abstract] [Full Text] [Related]

  • 13. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
    Olajiga OM, Adesoye OE, Emilolorun AP, Adeyemi AJ, Adeyefa EO, Aderibigbe IA, Adejumo SA, Adebimpe WO, Opaleye OO, Sule WF, Oluwayelu DO.
    Immunol Invest; 2017 Aug 31; 46(6):552-565. PubMed ID: 28742401
    [Abstract] [Full Text] [Related]

  • 14. Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex.
    Henss L, Yue C, Kandler J, Faddy HM, Simmons G, Panning M, Lewis-Ximenez LL, Baylis SA, Schnierle BS.
    Viruses; 2019 Jan 18; 11(1):. PubMed ID: 30669393
    [Abstract] [Full Text] [Related]

  • 15. Neutralizing Antibodies from Convalescent Chikungunya Virus Patients Can Cross-Neutralize Mayaro and Una Viruses.
    Martins KA, Gregory MK, Valdez SM, Sprague TR, Encinales L, Pacheco N, Cure C, Porras-Ramirez A, Rico-Mendoza A, Chang A, Pitt ML, Nasar F.
    Am J Trop Med Hyg; 2019 Jun 18; 100(6):1541-1544. PubMed ID: 31017081
    [Abstract] [Full Text] [Related]

  • 16. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
    Yoon IK, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, Thaisomboonsuk B, Klungthong C, Levy JW, Velasco JM, Roque VG, Salje H, Macareo LR, Hermann LL, Nisalak A, Srikiatkhachorn A.
    PLoS Negl Trop Dis; 2015 May 18; 9(5):e0003764. PubMed ID: 25951202
    [Abstract] [Full Text] [Related]

  • 17. Infection Pattern of Mayaro Virus in Aedes aegypti (Diptera: Culicidae) and Transmission Potential of the Virus in Mixed Infections With Chikungunya Virus.
    Kantor AM, Lin J, Wang A, Thompson DC, Franz AWE.
    J Med Entomol; 2019 Apr 16; 56(3):832-843. PubMed ID: 30668762
    [Abstract] [Full Text] [Related]

  • 18. Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products.
    Yue C, Teitz S, Miyabashi T, Boller K, Lewis-Ximenez LL, Baylis SA, Blümel J.
    Viruses; 2019 Mar 07; 11(3):. PubMed ID: 30866548
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela.
    Morales I, Rosenberger KD, Magalhaes T, Morais CNL, Braga C, Marques ETA, Calvet GA, Damasceno L, Brasil P, Bispo de Filippis AM, Tami A, Bethencourt S, Alvarez M, Martínez PA, Guzman MG, Souza Benevides B, Caprara A, Quyen NTH, Simmons CP, Wills B, de Lamballerie X, Drexler JF, Jaenisch T, IDAMS Clinical Study Group.
    PLoS Negl Trop Dis; 2021 Apr 07; 15(4):e0009336. PubMed ID: 33872309
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of Barmah Forest Virus, Chikungunya Virus and Ross River Virus Antibodies among Papua New Guinea Military Personnel before 2019.
    Kizu JG, Graham M, Grant R, McCallum F, McPherson B, Auliff A, Kaminiel P, Liu W.
    Viruses; 2023 Jan 30; 15(2):. PubMed ID: 36851608
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.